Aim: Adiponectin exhibits its biological effects through adiponectin receptors (AdipoR1 and AdipoR2), which are distributed in the kidneys, and activation of those receptors could prevent or ameliorate diabetic nephropathy. This study aimed to evaluate the associations between AdipoR single nucleotide polymorphisms (SNPs) and kidney function in an elderly Japanese population.
Introduction
Chronic kidney disease (CKD) is prevalent in approximately 8 -16% of the world's population 1) . The proportion of individuals with CKD increases markedly with age, and elderly adults are more vulnerable to the metabolic and hormonal disturbances associated with kidney function decline 2) . In aged populations, decreased kidney function has been suggested to be a contributing factor to atherosclerosis, which causes cardiovascular and cerebrovascular disease, and leads to high incidents of mortality [3] [4] [5] [6] [7] [8] . Furthermore, in older Copyright©2019 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.
Adiponectin is a major adipokine secreted by adipose tissue that plays an important role in regulating glucose and fat metabolism by enhancing insulin sensitivity and decreasing free fatty acid production. Adiponectin exhibits its biological effects through adiponectin receptors (AdipoR), including AdipoR1 and AdipoR2, both of which contain 7 transmembrane domains and are topologically distinct from the G protein-coupled receptor 20) . AdipoR1 mediates increases in 5´-adenosine monophosphate-activated protein kinase, and AdipoR2 activates peroxisome proliferatoractivated receptor (PPAR)-. AdipoR1 is widely expressed in muscle tissue, whereas AdipoR2 is expressed predominantly in the liver 21, 22) . In addition, other studies have shown that AdipoR1 and AdipoR2 are distributed in the kidneys, and their activation could prevent and ameliorate diabetic nephropathy, especially type 2 diabetes mellitus (T2DM) 23, 24) . Indeed, rats with CKD had increased renal expression of AdipoR1 and AdipoR2, which indicates that renal injury may cause compensatory upregulation of AdipoR1 and AdipoR2 in the kidneys to abate further injury. These renoprotective effects may partly be explained by ameliorating glomerular endothelial cell and podocyte injury by activating the AMP-activated protein kinase/ PPAR-pathway through AdipoR. Recent studies have demonstrated that AdipoR polymorphisms are associated with coronary artery disease, intima media thickness, and endothelial dysfunction 25) . Thus, we hypothesized that AdipoR polymorphism might affect kidney function via AdipoR activation signaling.
However, the association of AdipoR1 and AdipoR2 polymorphisms with kidney function in the elderly general population has not been fully understood. In this study, we evaluated the association of polymorphisms of AdipoR1 and AdipoR2 genes -7 single nucleotide polymorphisms (SNPs) for AdipoR1 (rs7539 542, rs1342387, rs16850797, rs12045862, rs16850799, rs2275737, and rs1539355) and 5 SNPs for AdipoR2 (rs11061925, rs10773983, rs10773986, rs10773988, and rs12230440) -with kidney function, as measured by cystatin C, in community-dwelling elderly adults.
Methods

Study Design
This is a prospective observational study of community-dwelling elderly adults aimed to evaluate the hematologic changes accompanying increasing age. All participants provided written informed consent to participate during their first visit and the study protocol was approved by the Ethics Committee of Nihon University School of Medicine in accordance with the Declaration of Helsinki. This study was conducted from 2004 330 Tris-EDTA buffer (1 ), and 0.046 µL TaqMan ® SNP genotyping assay mix (40 ) containing primers (final concentration, 331.2 nmol/L) and probes (final concentration, 73.6 nmol/L). Thermal cycling was performed using the GeneAmp 7700 system (Applied Biosystems, Foster City, CA, USA) under the following conditions: 50 cycles of 50 for 2 min and 95 for 10 min, and 50 cycles of 95 for 15 s and 60 for 1 min. Each 96-well plate contained 80 DNA samples of unknown genotype and four reaction mixtures containing reagents without DNA as controls, which were a necessary part of the 7700 signal processing system as outlined in the TaqMan ® Allelic Discrimination Getting Started Guide (Applied Biosystems, Foster City, CA, USA). The plates were read on the 7500 Real-time PCR System (version 1.4; Applied Biosystems, Foster City, CA, USA). Genotypes were determined visually based on the dye component fluorescent emission data depicted on X-Y scatter plots by the sequence detection system software. Genotypes were also determined automatically by the software's signal processing algorithms. The results of each scoring method were saved in separate output files for subsequent comparisons 38) .
SNP Quality Control
SNP-level quality control metrics were applied prior to the analyses. All genotyping SNPs showed: a call rate ≥ 95%, MAF ≥ 10%, Hardy -Weinberg equilibrium (HWE) p 0.05. Supplementary Table 1 shows the characteristics, MAF, and HWE P-values for the AdipoR1 and AdipoR2 SNPs.
Statistical Analyses
SPSS version 24 (SPSS Inc, Chicago, IL) was used for descriptive statistical analysis. Participant characteristics were summarized by the medians (interquartile range: 25-75 percentile) for continuous variables and percentages for categorical variables. The MannWhitney U test was used to compare the two groups.
Comparisons for categorized variables were tested with the Fisher exact test. Associations between AdipoR1 and AdipoR2 SNPs and the continuous variables (eGFRcys, total adiponectin, and HMW adiponectin) were tested using linear regression of additive (2 vs. 1 vs. 0 risk alleles) models of inheritance respectively adjusted for age, gender, BMI, MAP, total cholesterol, HDL cholesterol, GA, antidiabetic medications, and antihypertensive medications. In addition, the association of annual eGFRcys decline and the SNP which was significantly associated with baseline eGFRcys was tested via a logistic regression analysis of recessive (2 vs. 0/1 risk alleles) and dominant (2/1 vs. 0 risk alleles) models of inheritance and via linear regression of additive (2 vs. 1 vs. 0 risk alleles) models of inheritance adjusted for CICA GA-L kit (Asahi Kasei Pharma Corporation, Tokyo, Japan). Mean arterial pressure (MAP) was calculated as the diastolic pressure plus one-third of the pulse pressure. Because serum creatinine level is affected by muscle mass, we chose to use cystatin C to calculate eGFR. eGFR by cystatin C (eGFRcys) was calculated using the following equations: eGFRcys in male subjects (104 cystatin C .
Selection of SNPs
To investigate the genetic variability in each gene, we used a tag SNP approach. This tagging approach was applied to the entire set of common genetic variants in the AdipoR1 and AdipoR2 genes with a minor allele frequency (MAF) of ≥ 10% in the Japanese population (JPT) and a minimum r 2 threshold of 0.8. The tagging SNPs were selected using the NIEHS LD TAG SNP Selection database (https://snpinfo.niehs.nih.gov/snpinfo/ snptag.html). This process resulted in the selection of 9 and 11 tagging SNPs for the AdipoR1 and AdipoR2 genes, respectively. We chose genotype rs7539542 (UTR variant 3 prime), rs1342387 (intron variant), rs16850797 (intron variant), rs12045862 (intron variant), rs16850799 (intron variant), rs2275737 (intron variant), rs1539355 (intron variant), for AdipoR1 and rs10773983 (intron variant), rs10773988 (intron variant), rs12230440 (intron variant), for AdipoR2 after careful review of the literature and their MAFs in the Japanese population [28] [29] [30] [31] [32] [33] [34] . In addition, although they were not tag SNPs, rs1106 1925 (intron variant) and rs10773986 (intron variant) were evaluated because rs11061925 was shown the relation between the SNP and the metabolic parameter 35) , and rs10773986 had high MAF in the Japanese population.
Single-Nucleotide Polymorphism Analysis
Genomic DNA was extracted from peripheral blood leukocytes by the phenol-chloroform method 36) . Genotyping was performed using the TaqMan ® SNP genotyping assay (Applied Biosystems, Foster City, CA, USA) 37) . TaqMan ® SNP genotyping assays used were C_ 30041594_10 (rs7539542), C_37350_10 (rs1342387), C_32757249_10 (rs16850797), C_30887083_10 (rs 12045862), C_32757247_10 (rs16850799), C_1587 9522_10 (rs2275737), C_11457922_10 (rs1539355), C_26747669_10 (rs11061925), C_2633801_20 (rs107 73983), C_334325_10 (rs10773986), C_2636032_20 (rs10773988), and C_2636031_20 (rs12230440). PCR amplification was performed with a 5-µL final reaction volume, containing 2.5 µL TaqMan ® universal master mix, 2 ng DNA, 2.375 µL ultrapure water, 0.079 µL
Results
Baseline Characteristics of the Study Participants
The baseline characteristics of the study participants according to eGFRcys are shown in Table 1 . Of the 271 participants, 216 had an eGFRcys ≥ 60; the rest had values 60. The participants' ages were significantly higher in the group with eGFRcys 60 than in that with eGFRcys ≥ 60 (76.0 vs. 72.0 years, P 0.0001). Total cholesterol and HDL cholesterol were significantly higher in the eGFRcys ≥ 60 group than in the eGFRcys 60 group (205.0 mg/dL vs. 187.0 mg/dL, P 0.037; 57.0 mg/dL vs. 49.0 mg/dL, P 0.001). There were no statistically significant differences in sex, smoking status, BMI, SBP, DBP, MAP, GA, LDL cholesterol, TG, total adiponectin, HMW adiponectin, antihypertensive medications, and antidiabetic medications between the two groups.
Associations of AdipoR1 and AdipoR2 gene Polymorphisms with Kidney Function, Total Adiponectin, and HMW Adiponectin Levels
The associations between AdipoR gene SNPs and kidney function, total adiponectin, and HMW adiponectin levels are presented in Table 2 . The variant rs 12230440 was found to be significantly associated with age, gender, BMI, MAP, total cholesterol, HDL cholesterol, GA, antidiabetic medications, antihypertensive medications, and baseline eGFRcys. A Bonferroni correction was calculated based on the number of individual SNPs examined (0.05/12). Therefore, a P-value threshold of 0.0042 was used to determine the Bonferroni-corrected statistical significance for AdipoR1 and AdipoR2 SNPs. Total adiponectin level, HMW adiponectin level, MAP, HDL cholesterol, and GA were logtransformed to obtain better approximations of the normal distribution prior to analysis.
The haplotype-based analyses were conducted using SNPAlyze version 3.2. (DYNACOM Co., Ltd., Chiba, Japan). Haplotypes with estimated frequency of 5% were excluded from the analyses. To conduct the haplotype analysis that included common SNPs significantly or nominally associated with the study outcome variables, the P-value threshold of 0.0042 was accepted to determine the Bonferroni-corrected statistical significance (0.05/12). Multiple linear regression models were used to test the associations between the haplotypes and the study outcome variables. All the models were adjusted for age, gender, BMI, MAP, total cholesterol, HDL cholesterol, GA, antihypertensive medications, and antidiabetic medications. rs16750799 increased. However, this failed to reach the significance threshold after Bonferroni correction (corrected P 0.22 and 0.23).
Associations of Common Haplotypes of AdipoR2 with Kidney Function
To study the combined effect of AdipoR2 SNPs in the present study, the haplotype analysis only included combinations of those AdipoR2 variants that were significantly or nominally associated with baseline eGFRcys (i.e., rs11061925, rs10773983, and rs12230440). The haplotype analysis predicted three common haplotypes (frequency 5%). The most probable haplotype (CGT) had an estimated global frequency of 61%. As shown in Table 4 , the haplotype of TAG had significant association with eGFRcys, which reached the significance threshold after Bonferroni correction and adjustment for all the covariates ( 3.83, corrected P 0.019).
Discussion
In this study, we analyzed the associations of genetic variants of AdipoR1 and AdipoR2 genes and haplotypes of the AdipoR2 gene with kidney function and adiponectin level in elderly Japanese populations. One of the main findings was the significant association eGFRcys (analysis of recessive and dominant models for rs12230440 is shown in Supplementary Table 2 ). The analysis showed that eGFRcys tended to increase as the number of carriers of T alleles increased after adjustments for age, gender, BMI, MAP, GA, totalcholesterol, HDL cholesterol, antihypertensive medication, and antidiabetic medication and after Bonferroni correction ( 3.57, corrected P 0.034). In the case of the variants rs16850797, rs11061925, and rs107 73983, each of the G allele, allele C, and allele G showed a nominally significant association with higher eGFRcys as well. However, this failed to reach the significance threshold after Bonferroni correction (corrected P 0.13, 0.46, and 0.072).
In the prospective analysis, for which the average follow-up period was 4.59 years, median annual eGFRcys decline was 1.7 ml/min/1.73 m 2 . There was no significant association between rs12230440 variants and annual eGFRcys decline after multivariable adjustments when analyzed using recessive (P 0.39), dominant (P 0.28), and additive (P 0.16) models of inheritance ( Table 3) .
We could not detect significant associations between the AdipoR1 and AdipoR2 variants and HMW adiponectin levels. On the other hand, total adiponectin levels tended to significantly decrease as the number of major alleles G of the SNPs rs16850797 and study population revealed that an intronic variant, rs767 870, is associated with coronary artery disease, intimamedia thickness, and endothelial dysfunction 25) . In addition to 13 other AdipoR2 SNPs, this variant is also associated with fasting plasma triglyceride concentrations in Mexican 47) and Finnish 48) subjects. Other reports, studying the Finnish population, have demonstrated that AdipoR2 SNPs in rs11061937 and rs1058 322 were associated with CVD risk 34) . Furthermore, patients with an inherent homozygosity for the rare alleles rs11061946 and rs11061973 displayed an increased risk of converting from impaired glucose tolerance to T2DM.
One of the causes of the association between AdipoR SNPs and CVD risk might be described by the influence that AdipoR SNPs assume over the interaction between monocytes/macrophages and adiponectin, which is of critical importance in the anti-atherosclerotic protection offered by adiponectin 47) . Chronic inflammation is of key importance in the process of renal interstitial fibrosis via monocytes/macrophages [49] [50] [51] . Taking into consideration that rs11061937 and rs11061946 are SNPs tagged to rs12230440, which has been demonstrated in the present study to be associated with kidney function, one can hypothesize that the AdipoR2 SNP affects -albeit to an undetermined degree -fibrotic replacement in the renal interstitium under chronic inbetween the T allele of the rs12230440 SNP with higher eGFRcys, which remained significant even after the adjustment for covariates and Bonferroni correction. Furthermore, we found that carriers of the G allele of rs16850797 and rs10773983, and the C allele of rs11061925, showed a nominally significant association with higher eGFRcys. To our knowledge, this study is the first to analyze the association of AdipoR1 and AdipoR2 with eGFRcys in the elderly general population.
To date, numerous studies have been published providing details on the association between adiponectin and kidney function. With these studies comes the knowledge that patients with CKD have significantly increased levels of serum adiponectin [39] [40] [41] ; some studies have even proposed that elevated levels of serum adiponectin serve as a prognostic marker in CKD progression 42) . Others advocate the notion that adiponectin offers kidney protection under CKD conditions [43] [44] [45] . Dissecting the mechanisms of adiponectin at the finescale level, we now understand that this unique adipokine exerts its effects via interaction with specific adiponectin receptors, AdipoR1 and AdipoR2 20, 46) . Although, this study is the first to analyze the association of AdipoR SNPs with kidney function, there are some reports detailing the relationship between AdipoR SNPs and CVD risk. Recently, a cross-sectional flammatory conditions. The specific mechanism is unclear, but the susceptibility of AdipoR to adiponectin or the expression of AdipoR might be affected by this intronic SNP. Indeed, AdipoR1 and R2 double-knockout mice diminished adiponectin-binding effects, which are insulin resistance and impaired glucose tolerance, increased inflammation, and oxidative stress 52, 53) . These effects imply the possibility of anti-inflammatory effects on the kidney tissue via AdipoR. The specific mechanisms underlying the regulation of AdipoR1 and AdipoR2 remain an elusive subject; however, altered expression of AdipoR1 and AdipoR2 in various forms of tissue have been reported in numerous pathological conditions [54] [55] [56] [57] . These facts illustrate the possibility of AdipoR regulation being coordinated in an organ-specific manner and that genetic factors are one of the most crucial factors contributing to the expression and regulation of this gene. Consistent with this theory, Halvatsiotis et al. observed that the AdipoR2 variant rs767 870 altered AdipoR2 protein expression levels in peripheral monocytes 25) . Although the findings of this particular study are unique and offer insight into the association of AdipoR1 and AdipoR2 with eGFRcys, it does have several limitations. First, our study was limited by the relatively small sample population adopted for genetic association studies. This may weaken the discriminatory statistical power to identify true associations of genetic variants and clinical characteristics. Secondly, our study's participants were mainly restricted to the elderly population. Hence, it is difficult to apply our results to the young or middle aged Japanese populations. The third limitation lies in the fact that urinary protein levels were not evaluated. Urinary protein is a potentially key factor in kidney function decline. Lastly, we could not gather information pertaining to the use of cholesterol-lowering medications taken by the participants in this study. This is an important limitation because the use of such medications may alter serum adiponectin levels.
Conclusion
In this study, conducted in an elderly healthy Japanese cohort, we identified significant associations between an AdipoR2 SNP and eGFRcys that suggest a potential effect of AdipoR gene variants on kidney function. These findings contribute to the understanding of the mechanism by which adiponectin exerts its effects on kidney function via AdipoR. However, these associations need further clarification of AdipoR expression at both the genetic and protein levels. Additional studies that focus on the adiponectin pathway and gene-environment interactions in multi-ethnic subjects, will aid us in obtaining a deeper understanding of Data are shown as medians (25th and 75th percentile). Bonferroni Corr, Bonferroni Correction; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial pressure; GA, glycated albumin; HDL cholesterol, high-density lipoprotein cholesterol; LDL cholesterol, low-density lipoprotein cholesterol; TG, triglyceride; HMW adiponectin, high molecular weight adiponectin; eGFRcys, cystatin C-based estimated glomerular filtration rate.
